These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 26241497)
21. Targeting of ICAM-1-directed immunoliposomes specifically to activated endothelial cells with low cellular uptake: use of an optimized procedure for the coupling of low concentrations of antibody to liposomes. Hua S; Chang HI; Davies NM; Cabot PJ J Liposome Res; 2011 Jun; 21(2):95-105. PubMed ID: 20429814 [TBL] [Abstract][Full Text] [Related]
22. Soluble intercellular adhesion molecule-1 and natural killer cell activity in gastric cancer patients. Kaihara A; Iwagaki H; Gouchi A; Hizuta A; Isozaki H; Takakura N; Tanaka N Res Commun Mol Pathol Pharmacol; 1998 Jun; 100(3):283-300. PubMed ID: 9730008 [TBL] [Abstract][Full Text] [Related]
23. Expression of intercellular adhesion molecule-1 in mice with Pseudomonas-induced pyelonephritis. Yokoo A; Hirose T; Matsukawa M; Hotta H; Kunishima Y; Takahashi S J Urol; 1998 Aug; 160(2):592-6. PubMed ID: 9679934 [TBL] [Abstract][Full Text] [Related]
24. A potential hypothesis for 2019-nCoV infection therapy through delivery of recombinant ACE2 by red blood cell-hitchhiking. Aghili ZS; Mirzaei SA; Banitalebi-Dehkordi M J Biol Res (Thessalon); 2020 Dec; 27():17. PubMed ID: 34963881 [TBL] [Abstract][Full Text] [Related]
25. Nanoparticles disguised as red blood cells to evade the immune system. Fang RH; Hu CM; Zhang L Expert Opin Biol Ther; 2012 Apr; 12(4):385-9. PubMed ID: 22332936 [TBL] [Abstract][Full Text] [Related]
26. Hydrophobic interaction mediating self-assembled nanoparticles of succinobucol suppress lung metastasis of breast cancer by inhibition of VCAM-1 expression. Cao H; Zhang Z; Zhao S; He X; Yu H; Yin Q; Zhang Z; Gu W; Chen L; Li Y J Control Release; 2015 May; 205():162-71. PubMed ID: 25598420 [TBL] [Abstract][Full Text] [Related]
27. Red Blood Cell Hitchhiking: A Novel Approach for Vascular Delivery of Nanocarriers. Brenner JS; Mitragotri S; Muzykantov VR Annu Rev Biomed Eng; 2021 Jul; 23():225-248. PubMed ID: 33788581 [TBL] [Abstract][Full Text] [Related]
28. Marginated Neutrophils in the Lungs Effectively Compete for Nanoparticles Targeted to the Endothelium, Serving as a Part of the Reticuloendothelial System. Zamora ME; Essien EO; Bhamidipati K; Murthy A; Liu J; Kim H; Patel MN; Nong J; Wang Z; Espy C; Chaudhry FN; Ferguson LT; Tiwari S; Hood ED; Marcos-Contreras OA; Omo-Lamai S; Shuvaeva T; Arguiri E; Wu J; Rauova L; Poncz M; Basil MC; Cantu E; Planer JD; Spiller K; Zepp J; Muzykantov VR; Myerson JW; Brenner JS ACS Nano; 2024 Aug; 18(33):22275-22297. PubMed ID: 39105696 [TBL] [Abstract][Full Text] [Related]
29. Tumor suppression via paclitaxel-loaded drug carriers that target inflammation marker upregulated in tumor vasculature and macrophages. Park S; Kang S; Chen X; Kim EJ; Kim J; Kim N; Kim J; Jin MM Biomaterials; 2013 Jan; 34(2):598-605. PubMed ID: 23099063 [TBL] [Abstract][Full Text] [Related]
30. Surface engineering of inorganic nanoparticles for imaging and therapy. Nam J; Won N; Bang J; Jin H; Park J; Jung S; Jung S; Park Y; Kim S Adv Drug Deliv Rev; 2013 May; 65(5):622-48. PubMed ID: 22975010 [TBL] [Abstract][Full Text] [Related]
31. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Win KY; Feng SS Biomaterials; 2005 May; 26(15):2713-22. PubMed ID: 15585275 [TBL] [Abstract][Full Text] [Related]
32. Biological interactions and toxicity of nanomaterials in the respiratory tract and various approaches of aerosol generation for toxicity testing. Creutzenberg O Arch Toxicol; 2012 Jul; 86(7):1117-22. PubMed ID: 22418596 [TBL] [Abstract][Full Text] [Related]
33. Suppression of the reticuloendothelial system using λ-carrageenan to prolong the circulation of gold nanoparticles. Magaña IB; Yendluri RB; Adhikari P; Goodrich GP; Schwartz JA; Sherer EA; O'Neal DP Ther Deliv; 2015 Jul; 6(7):777-83. PubMed ID: 26228771 [TBL] [Abstract][Full Text] [Related]
34. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma. Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043 [TBL] [Abstract][Full Text] [Related]
35. Antibody-mediated lung endothelium targeting: in vivo model on primates. Balyasnikova IV; Yeomans DC; McDonald TB; Danilov SM Gene Ther; 2002 Feb; 9(4):282-90. PubMed ID: 11896467 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of anti-intercellular adhesion molecule-1 immunotherapy on immune responses to allogeneic hepatocytes in mice. Bumgardner GL; Li J; Heininger M; Orosz CG Hepatology; 1998 Oct; 28(4):1005-12. PubMed ID: 9755237 [TBL] [Abstract][Full Text] [Related]
37. In situ cellular hitchhiking of nanoparticles for drug delivery. Udofa E; Zhao Z Adv Drug Deliv Rev; 2024 Jan; 204():115143. PubMed ID: 38008185 [TBL] [Abstract][Full Text] [Related]
38. In vivo biodistribution of nanoparticles. Almeida JP; Chen AL; Foster A; Drezek R Nanomedicine (Lond); 2011 Jul; 6(5):815-35. PubMed ID: 21793674 [TBL] [Abstract][Full Text] [Related]
39. A numerical study on drug delivery Nikfar M; Razizadeh M; Paul R; Muzykantov V; Liu Y Nanoscale; 2021 Oct; 13(41):17359-17372. PubMed ID: 34590654 [TBL] [Abstract][Full Text] [Related]
40. Modelling the Transport of Nanoparticles under Blood Flow using an Agent-based Approach. Fullstone G; Wood J; Holcombe M; Battaglia G Sci Rep; 2015 Jun; 5():10649. PubMed ID: 26058969 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]